CardioMPO

News

Cleveland HeartLab business has ‘exploded’ (in a good way)

In the words of Cleveland HeartLab CEO Jake Orville, business has "exploded" since the beginning of the year, just months after his company launched a proprietary test for cardiac inflammation under a fee-for-service model. Cleveland HeartLab is a CLIA-certified and CAP-accredited reference lab that does an array of lipid and inflammation tests for clients, including CardioMPO, a proprietary test for cardiac inflammation marker myeloperoxidase.

By Mary Vanac
Hospitals

Cleveland HeartLab adds ‘bad cholesterol’ test to its portfolio

Cleveland HeartLab LLC has added a test of low-density lipoprotein, the so-called “bad cholesterol,” to its portfolio of heart-inflammation tests. The company’s NMR LipoProfile test measures and counts LDL particles, which carry cholesterol in the blood and can build up on artery walls, leading to atherosclerosis and cardiovascular disease.The higher the LDL particle level, the […]

By Brandon Glenn
sponsored content

A Deep-dive Into Specialty Pharma

A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.

By PurpleLab